• protist@mander.xyz
      link
      fedilink
      English
      arrow-up
      7
      ·
      7 months ago

      In the actual study, the subject had Type 2 diabetes, and the authors note that treating Type 1 will be much more difficult due to the immunology involved

      • Leather@lemmy.world
        link
        fedilink
        arrow-up
        3
        ·
        7 months ago

        Agreed, the article says all of this but it doesn’t make a lot of sense. This is generally the mindset everyone has been using to treat type 1. Type 1 is about production, type 2 is about resistance. This treatment doesn’t address resistance, it just makes more insulin. More insulin is not more better, and has consequences.